Evidence map›Paper›PMID 33090124›Full record

ArticleDiabetology international2020

Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes.

Hitomi Komatsu, Mariko Enomoto, Hisashi Shiraishi, Yasuyo Morita, Daisuke Hashimoto, Shuichi Nakayama, Shogo Funakoshi, Seiki Hirano, Yoshio Terada, Mitsuhiko Miyamura and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetology international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Hitomi KomatsuDepartment of Pharmacy, Kochi Medical School Hospital, Nankoku, Japan.
Mariko EnomotoDepartment of Pharmacy, Kochi Medical School Hospital, Nankoku, Japan.
Hisashi ShiraishiDepartment of Pharmacy, Kochi Medical School Hospital, Nankoku, Japan.
Yasuyo MoritaDepartment of Pharmacy, Kochi Medical School Hospital, Nankoku, Japan.
Daisuke HashimotoDepartment of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505 Japan.
Shuichi NakayamaDepartment of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505 Japan.
Shogo FunakoshiDepartment of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505 Japan.
Seiki HiranoDepartment of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505 Japan.
Yoshio TeradaDepartment of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505 Japan.
Mitsuhiko MiyamuraDepartment of Pharmacy, Kochi Medical School Hospital, Nankoku, Japan.
Shimpei FujimotoDepartment of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1007/s13340-020-00434-w.].

Identifiers

PMID33090124
PMCPMC7538514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.